"[1]." நோய் கட்டுப்பாடு மற்றும் தடுப்பு மையங்கள் 2009ஆம் ஆண்டு மார்ச் மாதம் 12ஆம் தேதியன்று பெறப்பட்டது.
doi.org
dx.doi.org
SA Waksman (1947). "What Is an Antibiotic or an Antibiotic Substance?". Mycologia39 (5): 565–569. doi:10.2307/3755196.
von Nussbaum F. et al. (2006). "Medicinal Chemistry of Antibacterial Natural Products– Exodus or Revival?". Angew. Chem. Int. Ed.45 (31): 5072–5129. doi:10.1002/anie.200600350. பப்மெட்:16881035.
Lindblad WJ (2008). "Considerations for Determining if a Natural Product Is an Effective Wound-Healing Agent". International Journal of Lower Extremity Wounds7 (2): 75–81. doi:10.1177/1534734608316028. பப்மெட்:18483011.
H. Landsberg (1949). "Prelude to the discovery of penicillin". Isis40 (3): 225–227.. doi:10.1086/349043.
Limbird LE (December 2004). "The receptor concept: a continuing evolution". Mol. Interv.4 (6): 326–36. doi:10.1124/mi.4.6.6. பப்மெட்:15616162.
Bosch F, Rosich L (2008). "The contributions of Paul Ehrlich to pharmacology: a tribute on the occasion of the centenary of his Nobel Prize". Pharmacology82 (3): 171–9. doi:10.1159/000149583. பப்மெட்:18679046.
Kingston W (June 2008). "Irish contributions to the origins of antibiotics". Irish journal of medical science177 (2): 87–92. doi:10.1007/s11845-008-0139-x. பப்மெட்:18347757.
HW Florey (1945). "Use of Micro-organisms for therapeutic purposes". Br Med J.2 (4427): 635–642. doi:10.1136/bmj.2.4427.635.
Pankey GA, Sabath LD. (March 2004). "Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections.". Clin Infect Dis.38 (6): 864–870. doi:10.1086/381972. பப்மெட்:14999632.
Wiegand I, Hilpert K, Hancock REW (January 2008). "Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC)of antimicrobial substances". Nat Protoc.3 (2): 163–175. doi:10.1038/nprot.2007.521. பப்மெட்:18274517.
Spanu T, Santangelo R, Andreotti F, Cascio GL, Velardi G, Fadda G (February 2004). "Antibiotic therapy for severe bacterial infections: correlation between the inhibitory quotient and outcome". Int. J. Antimicrob. Agents23 (2): 120–8. doi:10.1016/j.ijantimicag.2003.06.006. பப்மெட்:15013036.
Rhee KY, Gardiner DF (September 2004). "Clinical relevance of bacteriostatic versus bactericidal activity in the treatment of gram-positive bacterial infections". Clin. Infect. Dis.39 (5): 755–6. doi:10.1086/422881. பப்மெட்:15356797.
Finberg RW, Moellering RC, Tally FP, et al. (November 2004). "The importance of bactericidal drugs: future directions in infectious disease". Clin. Infect. Dis.39 (9): 1314–20. doi:10.1086/425009. பப்மெட்:15494908.
Slama TG, Amin A, Brunton SA, et al. (July 2005). "A clinician's guide to the appropriate and accurate use of antibiotics: the Council for Appropriate and Rational Antibiotic Therapy (CARAT) criteria". Am. J. Med.118 Suppl 7A: 1S–6S. doi:10.1016/j.amjmed.2005.05.007. பப்மெட்:15993671.
Weisberg E (May 1999). "Interactions between oral contraceptives and antifungals/antibacterials. Is contraceptive failure the result?". Clin Pharmacokinet36 (5): 309–13. doi:10.2165/00003088-199936050-00001. பப்மெட்:10384856.
Cowen LE (March 2008). "The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype". Nat. Rev. Microbiol.6 (3): 187–98. doi:10.1038/nrmicro1835. பப்மெட்:18246082.
Hawkey PM (September 2008). "The growing burden of antimicrobial resistance". J. Antimicrob. Chemother.62 Suppl 1: i1–9. doi:10.1093/jac/dkn241. பப்மெட்:18684701.
Ong S, Nakase J, Moran GJ, Karras DJ, Kuehnert MJ, Talan DA (2007). "Antibiotic use for emergency department patients with upper respiratory infections: prescribing practices, patient expectations, and patient satisfaction". Annals of emergency medicine50 (3): 213–20. doi:10.1016/j.annemergmed.2007.03.026. பப்மெட்:17467120.
Metlay JP, Camargo CA, MacKenzie T, et al. (2007). "Cluster-randomized trial to improve antibiotic use for adults with acute respiratory infections treated in emergency departments". Annals of emergency medicine50 (3): 221–30. doi:10.1016/j.annemergmed.2007.03.022. பப்மெட்:17509729.
Spurling G, Del Mar C, Dooley L, Foxlee R (2007). "Delayed antibiotics for respiratory infections". Cochrane database of systematic reviews (Online) (3): CD004417. doi:10.1002/14651858.CD004417.pub3. பப்மெட்:17636757.
Merril CR, Scholl D, Adhya SL (June 2003). "The prospect for bacteriophage therapy in Western medicine". Nat Rev Drug Discov2 (6): 489–97. doi:10.1038/nrd1111. பப்மெட்:12776223.
Lu TK, Collins JJ (2007). "Dispersing biofilms with engineered enzymatic bacteriophage". Proceedings of the National Academy of Sciences, USA104 (27): 11197–11202. doi:10.1073/pnas.0704624104.
Kirkup BC (2006). "Bacteriocins as oral and gastrointestinal antibiotics: theoretical considerations, applied research, and practical applications". Curr. Med. Chem.13 (27): 3335–50. doi:10.2174/092986706778773068. பப்மெட்:17168847.
Gillor O, Nigro LM, Riley MA (2005). "Genetically engineered bacteriocins and their potential as the next generation of antimicrobials". Curr. Pharm. Des.11 (8): 1067–75. doi:10.2174/1381612053381666. பப்மெட்:15777256.
Jones RL, Peterson CM, Grady RW, Kumbaraci T, Cerami A, Graziano JH (1977). "Effects of iron chelators and iron overload on Salmonella infection". Nature267 (5606): 63–65. doi:10.1038/267063a0. பப்மெட்:323727.
GovTrack.us. S. 742--109வது காங்கிரஸ் (2005): மருத்துவ சிகிச்சைக்கான நுண்ணுயிர் எதிர்ப்பிகளின் பாதுகாப்பு சட்டம் 2005, GovTrack.us (உள்நாட்டு சட்டவமைப்பு தரவுத்தளம்) <http://www.govtrack.us/congress/bill.xpd?bill=s109-742> (12, 2008ஆண்டு அணுகப்பட்டது)
GovTrack.us. ஹெச்.ஆர். 2562--109வது காங்கிரஸ் (2005): மருத்துவ சிகிச்சைக்கான நுண்ணுயிர் எதிர்ப்பிகளின் பாதுகாப்பு சட்டம் 2005, GovTrack.us (database of federal legislation) <http://www.govtrack.us/congress/bill.xpd?bill=h109-2562> (12, 2008ஆண்டு அணுகப்பட்டது)
von Nussbaum F. et al. (2006). "Medicinal Chemistry of Antibacterial Natural Products– Exodus or Revival?". Angew. Chem. Int. Ed.45 (31): 5072–5129. doi:10.1002/anie.200600350. பப்மெட்:16881035.
Lindblad WJ (2008). "Considerations for Determining if a Natural Product Is an Effective Wound-Healing Agent". International Journal of Lower Extremity Wounds7 (2): 75–81. doi:10.1177/1534734608316028. பப்மெட்:18483011.
Limbird LE (December 2004). "The receptor concept: a continuing evolution". Mol. Interv.4 (6): 326–36. doi:10.1124/mi.4.6.6. பப்மெட்:15616162.
Bosch F, Rosich L (2008). "The contributions of Paul Ehrlich to pharmacology: a tribute on the occasion of the centenary of his Nobel Prize". Pharmacology82 (3): 171–9. doi:10.1159/000149583. பப்மெட்:18679046.
Kingston W (June 2008). "Irish contributions to the origins of antibiotics". Irish journal of medical science177 (2): 87–92. doi:10.1007/s11845-008-0139-x. பப்மெட்:18347757.
Pankey GA, Sabath LD. (March 2004). "Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections.". Clin Infect Dis.38 (6): 864–870. doi:10.1086/381972. பப்மெட்:14999632.
Wiegand I, Hilpert K, Hancock REW (January 2008). "Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC)of antimicrobial substances". Nat Protoc.3 (2): 163–175. doi:10.1038/nprot.2007.521. பப்மெட்:18274517.
Spanu T, Santangelo R, Andreotti F, Cascio GL, Velardi G, Fadda G (February 2004). "Antibiotic therapy for severe bacterial infections: correlation between the inhibitory quotient and outcome". Int. J. Antimicrob. Agents23 (2): 120–8. doi:10.1016/j.ijantimicag.2003.06.006. பப்மெட்:15013036.
Rhee KY, Gardiner DF (September 2004). "Clinical relevance of bacteriostatic versus bactericidal activity in the treatment of gram-positive bacterial infections". Clin. Infect. Dis.39 (5): 755–6. doi:10.1086/422881. பப்மெட்:15356797.
Finberg RW, Moellering RC, Tally FP, et al. (November 2004). "The importance of bactericidal drugs: future directions in infectious disease". Clin. Infect. Dis.39 (9): 1314–20. doi:10.1086/425009. பப்மெட்:15494908.
Slama TG, Amin A, Brunton SA, et al. (July 2005). "A clinician's guide to the appropriate and accurate use of antibiotics: the Council for Appropriate and Rational Antibiotic Therapy (CARAT) criteria". Am. J. Med.118 Suppl 7A: 1S–6S. doi:10.1016/j.amjmed.2005.05.007. பப்மெட்:15993671.
Weisberg E (May 1999). "Interactions between oral contraceptives and antifungals/antibacterials. Is contraceptive failure the result?". Clin Pharmacokinet36 (5): 309–13. doi:10.2165/00003088-199936050-00001. பப்மெட்:10384856.
Hassan T (March 1987). "Pharmacologic considerations for patients taking oral contraceptives". Conn Dent Stud J7: 7–8. பப்மெட்:3155374.
Cowen LE (March 2008). "The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype". Nat. Rev. Microbiol.6 (3): 187–98. doi:10.1038/nrmicro1835. பப்மெட்:18246082.
Hawkey PM (September 2008). "The growing burden of antimicrobial resistance". J. Antimicrob. Chemother.62 Suppl 1: i1–9. doi:10.1093/jac/dkn241. பப்மெட்:18684701.
Ong S, Nakase J, Moran GJ, Karras DJ, Kuehnert MJ, Talan DA (2007). "Antibiotic use for emergency department patients with upper respiratory infections: prescribing practices, patient expectations, and patient satisfaction". Annals of emergency medicine50 (3): 213–20. doi:10.1016/j.annemergmed.2007.03.026. பப்மெட்:17467120.
Metlay JP, Camargo CA, MacKenzie T, et al. (2007). "Cluster-randomized trial to improve antibiotic use for adults with acute respiratory infections treated in emergency departments". Annals of emergency medicine50 (3): 221–30. doi:10.1016/j.annemergmed.2007.03.022. பப்மெட்:17509729.
Spurling G, Del Mar C, Dooley L, Foxlee R (2007). "Delayed antibiotics for respiratory infections". Cochrane database of systematic reviews (Online) (3): CD004417. doi:10.1002/14651858.CD004417.pub3. பப்மெட்:17636757.
Merril CR, Scholl D, Adhya SL (June 2003). "The prospect for bacteriophage therapy in Western medicine". Nat Rev Drug Discov2 (6): 489–97. doi:10.1038/nrd1111. பப்மெட்:12776223.
Kirkup BC (2006). "Bacteriocins as oral and gastrointestinal antibiotics: theoretical considerations, applied research, and practical applications". Curr. Med. Chem.13 (27): 3335–50. doi:10.2174/092986706778773068. பப்மெட்:17168847.
Gillor O, Nigro LM, Riley MA (2005). "Genetically engineered bacteriocins and their potential as the next generation of antimicrobials". Curr. Pharm. Des.11 (8): 1067–75. doi:10.2174/1381612053381666. பப்மெட்:15777256.
Jones RL, Peterson CM, Grady RW, Kumbaraci T, Cerami A, Graziano JH (1977). "Effects of iron chelators and iron overload on Salmonella infection". Nature267 (5606): 63–65. doi:10.1038/267063a0. பப்மெட்:323727.